LMS Courses

The Pharmacogenetics of Anthracycline-Related Cardiomyopathy in Survivors of Pediatric Cancers

The Pharmacogenetics of Anthracycline-Related Cardiomyopathy in Survivors of Pediatric Cancers   Agenda 1.     Welcome: (5 mins)- Greg Armstrong, MD, MSCE 4.     Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors:(25 mins)-  Smita Bhatia, MD, MPH 2.     Myocardial Determinants for the Metabolism and Toxicity of Anthracycline Drugs: (25 mins)-  Javier Blanco, PhD   3.     The Role of the Genome in Doxorubicin-Induced Cardiotoxicity: (25

The Pharmacogenetics of Anthracycline-Related Cardiomyopathy in Survivors of Pediatric Cancers Read More »